What are the contraindications for lisinopril?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraindications for Lisinopril

Lisinopril is absolutely contraindicated in patients with a history of angioedema or hypersensitivity to any ACE inhibitor, hereditary or idiopathic angioedema, and co-administration with aliskiren in diabetic patients. 1

Absolute Contraindications

Angioedema History

  • Any prior angioedema related to ACE inhibitor therapy constitutes a life-long contraindication to all ACE inhibitors – this is a permanent ban on the entire drug class, as emphasized by both the American Heart Association and American College of Cardiology. 2
  • Hereditary or idiopathic angioedema – patients with these conditions must never receive lisinopril. 1
  • Angioedema occurs in <1% of patients but is life-threatening and more frequent in Black individuals. 2

Hypersensitivity

  • Prior hypersensitivity reaction to any ACE inhibitor – cross-reactivity exists across the entire ACE inhibitor class. 1

Drug Interactions

  • Co-administration with aliskiren in diabetic patients – this combination is explicitly prohibited by the FDA. 1
  • Concomitant use with ARBs or direct renin inhibitors – combining ACE inhibitors with ARBs increases adverse events without improving outcomes and is contraindicated. 2

Additional Absolute Contraindications (Class Effect)

Pregnancy

  • Pregnancy (Category D) – ACE inhibitors cause fetal harm and are absolutely contraindicated during pregnancy. 2

Renal Vascular Disease

  • Bilateral renal artery stenosis – ACE inhibitors can precipitate acute renal failure in this setting. 2

Critical Safety Warnings (Not Absolute Contraindications but Require Extreme Caution)

Renal Impairment

  • Dosage adjustment is necessary when creatinine clearance is <30 mL/min, though not an absolute contraindication. 3
  • Monitor for worsening renal function and hyperkalemia, particularly in patients with chronic kidney disease. 2

Hyperkalemia Risk

  • Hyperkalemia occurred in 2.2% of hypertensive patients and 4.8% of heart failure patients in clinical trials. 1
  • Monitor serum potassium closely, especially with concomitant potassium-sparing agents or in patients with CKD. 2

Hypotension

  • First-dose hypotension occurred in 0.6% of hypertensive patients with normal renal function but 6.7% in those with impaired renal function. 4
  • In acute myocardial infarction patients, lisinopril increased hypotension incidence by 5.3%. 1

Common Pitfalls to Avoid

  • Never assume a patient with ACE inhibitor-induced cough can safely take lisinopril – while cough is not a contraindication, it occurs in up to 50% of certain populations and may require switching to an ARB. 2
  • Do not restart any ACE inhibitor after angioedema – this is a permanent contraindication requiring a 6-week washout before cautiously considering an ARB alternative under specialist supervision. 2
  • Avoid in patients already taking ARBs – dual RAAS blockade is contraindicated. 2

References

Guideline

Management of ACE‑Inhibitor Allergy and Alternative Therapies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The safety and tolerability of lisinopril in clinical trials.

Journal of cardiovascular pharmacology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.